NTRC Competitors and Similar CompaniesClear all
Nektar Therapeutics's competitors and similar companies include AVEO Pharmaceuticals and Candel Therapeutics.
 AVEO Pharmaceuticals AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. |  Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | ||
Founding Date | Founding Date 1990 | Founding Date 2001 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Boston, US HQ | Locations Needham, US HQ |
Employees | Employees 61821% increase | Employees 1912% increase | Employees 50 |
Valuation ($) | Valuation ($) 233.8 m | Valuation ($) 515.6 m | Valuation ($) 176.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) $42.3m (FY, 2021) | Revenue (est.) N/A |
Net income | Net income ($164.1m) (FY, 2025) | Net income ($53.3m) (FY, 2021) | Net income ($38.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 45m | Total funding raised $ 224m | Total funding raised $ 64.6m |
For sources of this data, please see the company profile
View Company Profiles
AVEO Pharmaceuticals
HQ
Boston, US
Employees
19↑ 12% increase
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
View companyCandel Therapeutics
HQ
Needham, US
Employees
50
Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View company